Raxibacumab | m-entrepreneurship.com

Product Name :
Raxibacumab

Search keywords :
Raxibacumab

drugId :
null

Target Vo:
Antrax lethal toxin

Target Vo Short Name :
Antrax lethal toxin

Moa_Name:
Antrax lethal toxin inhibitors

First Approval Country :
United States

First Approval Date Filter:
2012

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :
Human Genome Sciences Inc

Active Indication_Name:
Anthrax

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ocaratuzumab Technical Information
Casein Kinase 1 alpha Rabbit mAb Autophagy
Phospho-AMPK alpha 1 (Ser496) Antibody (YA226): Phospho-AMPK alpha 1 (Ser496) Antibody (YA226) is a non-conjugated and Rabbit origined monoclonal antibody about 64 kDa, targeting to Phospho-AMPK alpha 1 (S496). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts